Clinical Trial Update: Efficacy and Mechanisms of Naltrexone+Bupropion for Binge Eating Disorder [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial updates on efficacy and mechanisms of naltrexone plus bupropion for binge eating disorder, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder

Drugs mentioned

• Naltrexone/Bupropion (Naltrexone and bupropion)

Snippet

Sponsor: Yale University | Conditions: Binge-Eating Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-07-24